Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 8.68
+0.18 (2.12%)
Oct 22, 2026, 5:30 PM CEST
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 184.35 million as of October 22, 2026. It is the 20,169th most valuable company in the world and the 169th biggest in Switzerland. Its market cap has decreased by 35.59% in one year.
Market Cap
184.35M
Enterprise Value
190.03M
Revenue
9.62M
Global Rank
Country Rank
#169 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 184.35M, a decrease of -40.35%. That is a compound annual growth rate of -2.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 184.35M | -61.28% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.26B |
| Idorsia | 1.13B |
| Basilea Pharmaceutica AG | 839.62M |
| Santhera Pharmaceuticals Holding AG | 220.65M |
| BioVersys AG | 145.46M |
| Molecular Partners AG | 117.21M |
| Xlife Sciences AG | 52.94M |
| MindMaze Therapeutics Holding | 24.31M |